GLPBio

PolQi1

Catalog No.: GC75685Purity:>98.00%
PolQi1 is a selective inhibitor targeting the structure domain of DNA polymerase Polθ.

製品は研究用途にのみ使用できます。人体には使用できません。患者への販売は行っておりません。


PolQi1
Cas No.: 2607139-80-8
1mgIn Stock
$130.00
1
5mgIn Stock
$325.00
1
10mgIn Stock
$475.00
1
25mgIn Stock
$748.00
1
50mgIn Stock
$987.00
1
100mgIn Stock
$1,360.00
1
200mgIn Stock
$1,830.00
1

引用文献 (Citations)

現在、この製品の引用文献はありません。以下はGlpBio製品を引用した代表的な文献です。
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

製品説明 (Description)

PolQi1 is a selective inhibitor targeting the structure domain of DNA polymerase Polθ [1]. PolQi1 can target DNA repair pathways to promote homology-directed repair (HDR) by regulating DNA polymerase Polθ[2]. The combination of PolQi1 and AZD7648 can augment the integration efficiency and editing accuracy mediated by HDR, and reduce off-target mutations and translocations[3]. PolQi1 has been widely used to upgrade the accuracy of various genome engineering editing systems and to reduce the off-target editing effects of active nuclease systems [4].

References:
[1] Mentani A, Maresca M, Shiriaeva A. Prime editing: Mechanistic insights and DNA repair modulation[J]. Cells, 2025, 14(4): 277.
[2] Haider S, Mussolino C. Fine-tuning homology-directed repair (HDR) for precision genome editing: current strategies and future directions[J]. International Journal of Molecular Sciences, 2025, 26(9): 4067.
[3] Wimberger S, Akrap N, Firth M, et al. Simultaneous inhibition of DNA-PK and Polϴ improves integration efficiency and precision of genome editing[J]. Nature communications, 2023, 14(1): 4761.
[4] Dacquay L C, Antoniou P, Mentani A, et al. Dual inhibition of DNA-PK and Polϴ boosts precision of diverse prime editing systems[J]. Nature Communications, 2025, 16(1): 4290.

製品資料 (Product Documents)

Purity:>98.00%Appearance:A solid

化学的性質 (Chemical Properties)

CAS番号
2607139-80-8
分子式
C18H14ClF5N4O2
分子量
448.77
溶解性
DMSO: 100 mg/mL (222.83 mM; Need ultrasonic)
保存条件
-20°C
一般的な注意事項
製品の溶解性データに基づいて適切な溶媒を選択してください。調製後は、凍結融解の繰り返しを避けるため、ストック溶液を小分けしてください。
ストック溶液は、-80°Cで保存する場合は6か月以内、-20°Cで保存する場合は1か月以内に使用してください。
溶解性を高めるには、チューブを37°Cに温め、適切な時間超音波処理してください。
配送条件
評価用サンプルは保冷剤とともに発送します。その他の容量は室温で発送し、ご要望に応じて保冷剤を同梱します。

計算ツール (Calculators)モル濃度 / 希釈 / 分子量 / 単位変換 / in vivo製剤 / 溶解度

g/mol

Reviews

Review for PolQi1

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%